Dr Reddy's Laboratories, HCL Technologies, and Aurobindo Pharma have achieved 52-week highs and solidified their positions as market leaders. Dr Reddy's Laboratories has a market capitalization of Rs 84,254.00 crore and a P/E ratio of 18.7, while HCL Technologies has a market capitalization of Rs 317,037.50 crore and a P/E ratio of 21.3. Aurobindo Pharma has a market capitalization of Rs 42,213.90 crore and a P/E ratio of 21.9, highlighting their growth potential and investor appeal. Their successes serve as a reminder of the growth potential within the BSE 100 index.
